By Patricio Ledesma, Founder & CEO, Sofpromed
Table of Contents
My name is Patricio Ledesma, and for more than a decade I have dedicated my professional life to helping biotechnology companies, pharmaceutical sponsors, academic investigators, and research institutions conduct successful clinical trials.
Clinical research is not simply my profession.
It is my passion.
Every clinical trial represents an opportunity to bring a new treatment closer to patients who need it.
Whether I am working on an early-phase oncology study, a global Phase 3 program, or an investigator-initiated academic trial, I never forget the ultimate goal: improving lives through better science.
How I Started Sofpromed
In 2012, I founded Sofpromed from scratch.
There were no investors.
There was no external ownership.
There was no large corporate structure behind the company.
I did have the great support of one of my best friends, Dr. Javier Martín, who is a brilliant Medical Oncologist.
I built Sofpromed with a simple vision:
To provide high-quality, cost-efficient clinical research services while maintaining the personal attention that many sponsors struggle to find in larger CROs.
Today, I remain the sole owner of Sofpromed, and that independence allows us to focus on what matters most: our clients and their studies.
Unlike many organizations where sponsors become just another project number, I have always wanted Sofpromed to be a company where each client receives direct support, honest communication, and practical solutions.
My Academic Background
To strengthen my expertise in clinical research methodology, I completed a Master's Degree in Clinical Trials from the University of Seville, Spain.
This formal training provided me with a strong foundation in:
- Clinical trial design
- Regulatory requirements
- Biostatistics
- Good Clinical Practice (GCP)
- Clinical operations
- Data quality management
- Drug development strategies
However, as every clinical research professional knows, some of the most valuable lessons come from real-world experience.
Managing More Than 100 Clinical Trials
During my career, I have managed more than 100 clinical trials and research projects.
These studies have ranged from small academic investigations to large international multicenter programs.
My experience includes:
|
Area |
Experience |
|
Oncology Clinical Trials |
Extensive |
|
Rare Cancer Studies |
Extensive |
|
Academic Research |
Extensive |
|
Commercial Studies |
Extensive |
|
Global Multicountry Trials |
Extensive |
|
Site Management |
Extensive |
|
Patient Recruitment Strategies |
Extensive |
|
Clinical Operations |
Extensive |
|
CRO Oversight |
Extensive |
|
Regulatory Coordination |
Extensive |
Working across different therapeutic areas, countries, and development phases has taught me how to anticipate challenges before they become problems.
That experience allows me to help sponsors move faster, reduce costs, and make better operational decisions.
My Main Specialty: Cancer Clinical Trials
While I have worked in multiple therapeutic areas, my greatest expertise is in oncology clinical trials.
Cancer research is one of the most challenging and complex areas of drug development.
The studies are often characterized by:
- Complex protocols
- Biomarker-driven recruitment
- Competitive enrollment environments
- Time-sensitive endpoints
- Global regulatory requirements
- High operational costs
Over the years, I have supported studies involving:
- Breast cancer
- Lung cancer
- Gastrointestinal tumors
- Gynecological cancers
- Sarcomas
- Pediatric oncology
- Hematologic malignancies
- Rare cancers
Many of the biotech companies I work with are developing innovative therapies that have the potential to change standards of care for cancer patients worldwide.
Helping these companies navigate clinical development is one of the most rewarding aspects of my career.
Experience in Both Academic and Commercial Research
One advantage I bring to sponsors is that I understand both worlds.
I have managed:
Academic Studies
These projects often face challenges such as:
- Limited budgets
- Investigator-driven operations
- Grant funding constraints
- Resource limitations
Commercial Clinical Trials
These studies often require:
- Aggressive timelines
- Regulatory precision
- Multinational coordination
- Investor expectations
- Large-scale operational execution
Because I have worked extensively in both environments, I can often identify practical ways to improve efficiency without compromising quality.
My Mission: Helping Biotech Companies Run Successful and Cost-Efficient Trials
One of my biggest motivations is helping biotech companies optimize their clinical development programs.
Many emerging biotech organizations face enormous pressure.
They need to:
- Preserve cash runway
- Reach critical milestones
- Attract investors
- Generate high-quality data
- Accelerate development timelines
Unfortunately, inefficient study execution can significantly increase costs and delay important milestones.
My goal is to help sponsors avoid these problems.
I am constantly looking for ways to:
- Improve feasibility assessments
- Accelerate patient recruitment
- Optimize site networks
- Reduce operational costs
- Improve study quality
- Shorten timelines
In my experience, successful clinical trials require both scientific excellence and operational excellence.
You need both.
Why Clients Work Directly With Me
One aspect of Sofpromed that many clients appreciate is my personal involvement.
I do not disappear after a contract is signed.
I become actively involved in the project.
When a challenge arises, clients know they can contact me directly.
When enrollment is behind schedule, I want to help solve it.
When site performance becomes an issue, I want to evaluate solutions.
When a sponsor needs advice about feasibility, country selection, recruitment strategy, CRO oversight, or operational planning, I want to contribute my experience.
This hands-on approach has been one of the defining characteristics of Sofpromed since the company was founded.
I Truly Care About My Customers
Perhaps the most important thing I would like readers to know is that I genuinely care about the success of my clients.
Clinical trials are not easy.
There are always unexpected challenges.
Recruitment may be slower than anticipated.
Budgets may become tight.
Timelines may shift.
Operational issues may emerge.
During those moments, sponsors need more than a service provider.
They need a trusted partner.
I have always believed that long-term relationships are built on trust, responsiveness, honesty, and commitment.
That is how I approach every study.
Looking Forward
After managing more than 100 clinical research projects and building Sofpromed from the ground up, I remain as excited about clinical research as I was when I started.
The future of medicine depends on innovative clinical trials.
Whether you are a biotech executive preparing your first study, an academic investigator pursuing groundbreaking research, or a pharmaceutical company seeking an experienced partner, my mission remains the same:
To help you conduct high-quality, cost-efficient, and successful clinical trials while providing the personal attention and commitment that every sponsor deserves.
And if challenges arise during your study, you can always reach out to me directly.
Because your success matters to me.
